This paper reports the detection
of the inflammatory and sepsis-related
biomarker, interleukin-6 (IL-6), in human blood plasma using functionalized
screen-printed electrodes (SPEs) in conjunction with a thermal detection
methodology, termed heat-transfer method (HTM). SPEs are functionalized
with antibodies specific for IL-6 through electrodeposition of a diazonium
linking group and N′-ethylcarbodiimide hydrochloride
(EDC) coupling, which was tracked through the use of cyclic voltammetry
and Raman spectroscopy. The functionalized SPEs are mounted inside
an additively manufactured flow cell and connected to the HTM device.
We demonstrate the ability to detect IL-6 at clinically relevant concentrations
in PBS buffer (pH = 7.4) with no significant interference from the
similarly sized sepsis-related biomarker procalcitonin (PCT). The
limit of detection (3σ) of the system is calculated to correspond
to 3.4 ± 0.2 pg mL–1 with a working range spanning
the physiologically relevant concentration levels in both healthy
individuals and patients with sepsis, indicating the sensitivity of
the sensor is suitable for the application. Further experiments helped
provide a proof-of-application through the detection of IL-6 in blood
plasma with no significant interference observed from PCT or the constituents
of the medium. Due to the selectivity, sensitivity, straightforward
operation, and low cost of production, this sensor platform has the
potential for use as a traffic light sensor for the multidetection
of inflammatory biomarkers for the diagnosis of sepsis and other conditions
in which the rapid testing of blood biomarkers has vital clinical
application.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.